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Postoperative cognitive dysfunction (POCD) may be driven by transference of the innate
immune response to the brain after aseptic surgical damage. Macrophages are key
mediators of innate immunity that can display a pro-inflammatory M1 phenotype or an
anti-inflammatory M2 phenotype. Erythropoietin (EPO) is a hematopoietic hormone that
exerts anti-inflammatory effects by influencing macrophage function. We hypothesized
that EPO would prevent POCD by promoting macrophage phenotype switching to
the M2 phenotype post-surgery. To evaluate the effects of EPO on POCD and
macrophage polarization post-surgery, we administered EPO (5,000U/kg) with or without
an arginase inhibitor (amino-6-boronohexanoic acid, 10mg/kg) to ICR mice before and
after abdominal surgery. Forty-eight hours post-surgery, we assessed memory, synapse
function, and macrophage/microglial phenotypes in the spleen and hippocampus.
We also investigated M1/M2 phenotypes in RAW264.7 and BV2 cells stimulated
with lipopolysaccharide and interferon-γ (M1 inducers) in the presence or absence
of EPO. EPO prevented POCD, decreased surgery-related synaptic dysfunction, and
attenuated pro-inflammatory cytokine generation in the hippocampus. Moreover, EPO
suppressed M1-related genes expression and promoted M2 genes expression in the
spleen and hippocampus post-surgery. Furthermore, EPO decreased the proportions of
macrophages/microglia expressing an M1 surface marker (CD40) and increased those
expressing an M2 surface marker (CD206). Arginase inhibition abolished the beneficial
effects of EPO on POCD. In vitro, EPO treatment promoted switching of RAW264.7 and
BV2 cells stimulated with M1 inducers to an M2 phenotype. In conclusion, EPO prevents
POCD by promoting macrophage phenotype switching toward the M2 phenotype.
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INTRODUCTION
Postoperative cognitive dysfunction (POCD) is a major neurological complication after surgery
that adversely affects the quality of life, social independence, and mortality of patients (Steinmetz
et al., 2009; Mashour et al., 2015). Even acute cognitive decline after surgery can result in persistent
cognitive dysfunction (Saczynski et al., 2012; Inouye et al., 2016). Although several mechanisms
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have been associated with the development of POCD, mounting
preclinical evidence suggests that inflammation in the brain
(neuroinflammation) induced by systemic inflammation after
surgery is a core pathogenic factor (Cibelli et al., 2010; Terrando
et al., 2010; Hovens et al., 2014; Vacas et al., 2014). Furthermore,
a recent meta-analysis confirmed that the systemic inflammatory
response to surgery is associated with POCD in clinical settings
(Peng et al., 2013).
Surgical interventions inevitably damage tissue and lead to
activation of the innate immune response. Macrophage act
as key mediators of innate immunity. Macrophages that are
activated after surgery can infiltrate the brain parenchyma
to induce microglial activation and neuroinflammation. The
resulting increase in pro-inflammatory cytokine expression,
especially within hippocampus, eventually leads to cognitive
dysfunction (Wan et al., 2007; Dilger and Johnson, 2008;
Terrando et al., 2011; Degos et al., 2013). However, macrophages
can be differentially activated in response to environmental cues
or pathophysiological conditions (Wang et al., 2014). Activated
macrophage phenotypes include the classically activated M1
phenotype and the alternatively activatedM2 phenotype. TheM1
phenotype is induced by microbial products, pro-inflammatory
cytokines, and destructive inflammatory mediators, such as
interleukin (IL)-12, IL-23, nitric oxide, and reactive oxygen
species. In contrast, the M2 phenotype can be induced by IL-4,
IL-10, or IL-13, and this phenotype facilitates the clearance of
cellular debris through phagocytosis, as well as the production
of protective and trophic factors, such as ornithine and
polyamines, through the arginase pathway. Therefore, in various
disease conditions, the M1 phenotype initiates and maintains
inflammation, while the M2 phenotype prevents or resolves
chronic inflammation. To date, there is little evidence regarding
the association between POCD and patterns of macrophage
activation.
Erythropoietin (EPO) is a 30.4-kDa glycoprotein hormone
that promotes red blood cell production by inhibiting the
apoptosis of erythroid progenitor cells (Lombardero et al., 2011).
Accordingly, EPO has been applied in clinical settings for the
prevention and management of perioperative anemia (Steuber
et al., 2016). The cognate receptor for EPO is expressed in
various cell types; thus, EPO has pleiotropic actions in non-
hematopoietic as well as hematopoietic cells (Lombardero et al.,
2011). Immune cells also express the EPO receptor and are
thus subject to modulation by EPO (Brines and Cerami, 2012).
Several studies have reported that the treatment of activated
macrophages with EPO significantly reduces the production
of M1-like pro-inflammatory mediators and enhances M2-
associated phagocytic activity (Nairz et al., 2011; Liu et al., 2014;
Luo et al., 2016). Since EPO is commercially available in the
form of recombinant human EPO (rhEPO) and widely used in
the treatment of anemia now, it is very important to identify its
other therapeutic potentials or mechanisms of action. Therefore,
in the present study, we tested whether EPO treatment would
promote the activation of macrophage/microglia toward the M2
phenotype, reduce neuroinflammation, and thus limit the extent
of post-surgical cognitive dysfunction. We examined cognitive
dysfunction after abdominal surgery because abdominal surgery
is one of the most commonly performed surgeries and is reported
to induce POCD in clinical settings (Monk et al., 2008). The
model of abdominal surgery adopted in this study includes
physical irritation to the viscera and mesenteric ischemia-
reperfusion to mimic human exploratory abdominal surgery.
MATERIALS AND METHODS
Animals
All experimental procedures and animal care were approved by
the Institutional Animal Care and Use Committee of Yonsei
University, and were conducted in accordance with the Guide
for the Care and Use of Laboratory Animals approved by the
Association for the Assessment and Accreditation of Laboratory
Animal Care. Adult male ICR mice (Orient, Seongnam,
GyeongGi-Do, South Korea; aged 8–10 weeks) were used in the
experiment. All mice were housed in a controlled animal facility
at Yonsei University. The mice were housed in groups of five per
cage on a 12-h light/dark cycle with food and water available ad
libitum.
Experimental Design and Animal Grouping
The mice were randomly divided into four groups as follows:
(1) control, (2) surgery, (3) EPO-control, and (4) EPO-surgery.
Mice in the control group remained naïve to the experimental
conditions. Mice in the EPO-control group only received rhEPO
treatment, without any anesthetic or surgical procedures. Mice
in the surgery group underwent abdominal surgery only. Finally,
mice in the EPO-surgery group received rhEPO treatment and
underwent abdominal surgery. At 1 h prior to surgery, mice
in the EPO-surgery received rhEPO (5,000U/kg, subcutaneous
[s.c].; Epokine 1,000 U/ml, CJ Healthcare, Seoul, South Korea)
diluted in 200 µl of phosphate-buffered saline (PBS). They
received a second injection 24 h after the first injection. Mice
in the EPO-control group received two injections of rhEPO
with a 24 h interval between them. For surgery, the animals
were anesthetized with 3% sevoflurane and maintained under
anesthesia with 2% sevoflurane in a mixture of oxygen and air
(inspired oxygen fraction, 0.3).Mice were placed on a heating pad
while anesthetized to prevent hypothermia. Abdominal surgery
was performed as previously described with some modifications
(Barrientos et al., 2012; Hovens et al., 2014). Briefly, a vertical
incision was made along the midline, along the linea alba, and
the intestines were exteriorized and rubbed with the operator’s
fingers for 30 s. In addition, the superior mesenteric artery was
dissected and clamped for 40min. After removal of the clamp,
the intestine was placed back into the peritoneal cavity and the
abdominal muscle and skin were closed using suture. Tramadol
(20 mg/kg intraperitoneal [i.p.]) was administered only to the
mice undergoing surgery for post-operative analgesia.
Cognitive function was assessed using a behavioral test
battery carried out 48 h post-surgery. The levels of inflammatory
cytokines (IL-1β and tumor necrosis factor alpha [TNF-α]) and
extracellular field potentials in the hippocampus were measured
at the same time point in order to evaluate hippocampal synaptic
function. To assess the pattern of macrophage/microglial
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activation, mRNA expression levels of selectedM1-related (TNF-
α and CXCL10) and M2-related (arginase-1 and IL-10) genes
were measured in spleen and hippocampus tissues at 6 and
48 h post-surgery. Furthermore, proportions of M1- and M2-
like macrophages/microglia were also assessed in the spleen and
hippocampus tissues using flow cytometry. For the collection of
spleen and hippocampal tissues, mice were anesthetized with a
mixture of 30mg/kg zoletil (Virbac Laboratory, Carros, France)
and 10mg/kg xylazine (Bayer Korea Ltd., Seoul, South Korea)
and euthanized by transcardial perfusion with 0.9% normal saline
at each time point. The hippocampus was isolated under a
dissecting microscope as previously described (Spijker, 2011).
Finally, to confirm a beneficial role for M2 macrophage
activation in cognitive function post-surgery, we performed an
additional study in which a selective arginase inhibitor was
co-administered with rhEPO prior to surgery. Arginase activity
mediates most M2-associated anti-inflammatory effects (Pesce
et al., 2009) and is positively associated with M2 macrophages
(Yang andMing, 2014). Therefore, we assessed cognitive function
and levels of inflammatory cytokines in the hippocampus at 48 h
post-surgery in mice that were treated with both rhEPO and an
arginase inhibitor (EPO-surgery-AI group). Mice in the EPO-
surgery-AI groups received rhEPO (5,000 U/kg, s.c.; Epokine
1,000 U/ml, CJ Healthcare, Seoul, South Korea) diluted in 200
µl of phosphate-buffered saline (PBS) at the same time points
as the EPO-Surgery group (1 h before surgery and 24 h after the
first administration), and the selective arginase inhibitor, amino-
6-boronohexanoic acid (10 mg/kg, i.p.; ABH ammonium salt,
Enzo Life Sciences, Farmingdale, NY, USA) dissolved in PBS
30min before each rhEPO injection. The dose of the selective
arginase inhibitor was selected based on a previous study in
which 10 mg/kg of the ABH salt abolished arginase activity in
M2 phenotype macrophages (Amantea et al., 2016).
Neurobehavioral Assessment
Neurobehavioral function was assessed by three different types
of tests at 48 h post-surgery. Open field testing was performed
to assess exploratory activity. Mice were tested in a square open
field arena (40 × 40 × 40 cm) and behavior was recorded
for 5min. Total distance moved was assessed. The passive
avoidance and novel object recognition tests were selected to
assess hippocampal-dependent function (Antunes and Biala,
2012; Izquierdo et al., 2016). Passive avoidance testing was used
to evaluate learning and memory in the mice. The apparatus
used was a rectangular chamber divided into dark and lighted
compartments. During the acquisition phase, mice were placed
into the lighted compartment; when mice entered the dark
compartment, they received an electric shock (0.5mA) for 3 s.
In the test phase, mice were place in the lighted compartment
and the latency to enter the dark compartment was measured
and recorded. The acquisition trial was performed at 24 h
after surgery and the test trial was performed at 48 h post-
surgery. Novel object recognition test was adopted to evaluate
cognition, specifically recognition memory, in the mice. During
the habituation phase, each mouse was allowed to explore the
black box (40 × 40 × 40 cm) used for testing for 5min.
During the familiarization phase, the mice were placed into the
black box, which contained two identical objects (A + A) and
were allowed to explore for 5min. During the test phase, each
mouse was returned to the box with the two objects, where one
object was changed to a novel object (A + B), and they were
allowed to explore for 3min. During both the familiarization
and test phases, the time spent in exploring each object was
measured and recorded. At the end of each test, the apparatus and
objects were cleaned with 50% ethanol. The habituation phase
was performed immediately prior to surgery, the familiarization
phase was performed at 24 h post-surgery, and the test trial was
performed at 48 h post-surgery.
All the neurobehavioral tests were recorded on video and
analyzed with an image analyzing system (SMART v2.5.21
software and SMART video Tracking system, Panlab Harvard
Apparatus, Barcelona, Spain) by an assessor blinded to the
treatment groups. Some mice performed the open field test and
the passive avoidance test sequentially. The remaining mice only
performed the novel object recognition test.
Electrophysiology
To investigate the response of the hippocampal CA1 circuit
to Schaffer collateral (SC) input, hippocampal brain slices
(thickness, 400µm) were prepared from the mice at 48 h post-
surgery. Briefly, the mice were anesthetized with sevoflurane
and the brain was rapidly cooled via transcardial perfusion
with ice-cold sucrose-artificial cerebrospinal fluid (aCSF). Brains
were next removed and placed in the iced-cold sucrose-
aCSF. Coronal slices were allowed to recover in aCSF for
30min at 35◦C, and then incubated in aCSF for 1–4 h at
room temperature (23–25◦C) before being placed into the
recording chamber. Standard aCSF contained 124mM NaCl,
2.5mM KCl, 2.5mM CaCl2, 1.3mMMgSO4, 1.0mM NaH2PO4,
26.2mM NaH2CO3, 11mM glucose, 2mM Na pyruvate, and
1mM Na ascorbate, saturated with 95% O2/5% CO2. Sucrose-
aCSF contained 195.5mM sucrose, 2.5mM KCl, 2.5mM CaCl2,
1.3mM MgSO4, 1mM NaH2PO4, 26.2mM NaHCO3, 11mM
glucose, 2mM Na pyruvate, and 1mM Na ascorbate, saturated
with 95% O2/5% CO2. All experiments were conducted at 27–
29◦C. For electrophysiological experiments, electrodes with 3–6
M pipette resistance were used and whole-cell recordings were
obtained from neurons under visual guidance using infrared-
differential interference contrast optical guidance. The CA3 and
dentate gyrus regions were cut away immediately prior to long-
term potentiation (LTP) experiments to isolate the CA1 area.
The stimuli were applied to the SC pathway and field excitatory
postsynaptic potentials (fEPSPs) were recorded from the CA1
stratum radiatum using an extracellular glass pipette (3–5 M)
filled with aCSF. SC/commissural fibers in the stratum radiatum
were stimulated using a concentric bipolar electrode placed 200–
300µm from the recording pipette. The test stimulation in
all fEPSP experiments was 0.1Hz in frequency and 0.2ms in
duration. An input/output (I/O) curve was plotted by recording
fEPSPs in response to stimulation with increasing voltages (0.3–
0.9V). The stimulus for LTP was a voltage that elicited 50% of
the maximum fEPSP. Baseline synaptic responses were recorded
for 20min and then LTP was induced with two high-frequency
stimulation trains (100Hz frequency, 1 s duration) separated
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by a 20-s inter-train interval. The recordings were performed
every 30 s for 1 h using an axopatch 1D amplifier (Molecular
Devices, Sunnyvale, CA, USA) digitized at 10KHz and filtered at
2 KHz with Digidata 1322A and pClamp 9.0 software (Molecular
Devices).
Cell Cultures and Treatments
Mouse microglial BV2 cells were cultured in RPMI 1640
medium (HycloneTM, GE Healthcare Life Sciences, Logan,
UT, USA) supplemented with 10% fetal bovine serum (FBS)
and 1% penicillin-streptomycin solution. Mouse macrophage
RAW 264.7 cells (KCIB, Seoul, Korea) were cultured in high-
glucose Dulbecco’s modified eagle medium (HycloneTM, GE
Healthcare Life Sciences) supplemented with 10% FBS and 1%
penicillin-streptomycin solution. Cells were incubated at 37◦C
in a humidified atmosphere in the presence of 5% CO2. For
experiments, each cell line was seeded in six well plates at a
density of 2 × 106 per well 24 h prior to treatment. Cells were
next pretreated with 5 U/ml rhEPO or PBS for 30min and then
stimulated with 50 ng/ml lipopolysaccharide (LPS) combined
with 20 ng/ml interferon (IFN)-γ or PBS for 24 h.
Enzyme-Linked Immunosorbent Assay
(ELISA)
For the in vivo experiment, the hippocampi were obtained at
48 h post-surgery and stored at −80◦C until use. To measure
levels of hippocampal IL-1β and TNF-α, the hippocampal tissues
were lysed using tissue protein extraction reagent (T-PER R©
Tissue Protein Extraction Reagent, Thermo ScientificTM,
Waltham, MA, USA) containing protease and phosphatase
inhibitor cocktail (100X Halt protease and phosphatase
inhibitor cocktail, #1861281 Thermo ScientificTM) added at
a volume of 20 µl per 1mg of tissue. The tissues were then
homogenized and centrifuged at 13,000 rpm for 10min to obtain
sample supernatants. Supernatant protein concentrations were
measured with a BCA Protein Assay Kit (Thermo ScientificTM)
according to the manufacturer specifications. Levels of mouse
IL-1β and TNF-α in hippocampal lysates were assayed using
high-sensitivity ELISA kits (Quantikine R© ELISA, R&D Systems
Inc., Minneapolis, MN, USA) according to the manufacturer
specifications. Briefly, samples were added to the assay plates
at a volume of 50 µl/well and incubated for 2 h at room
temperature. After washing plates with the wash buffer from
the kit, mouse IL-1β and TNF-α conjugates were added to
each well and incubated for 2 h. The reaction was stopped
and well absorbances were read at 450 nm using a microplate
reader. For the in vitro experiment, we measured levels of IL-12
and IL-10 in BV2 and RAW 264.7 cell culture supernatants.
Briefly, supernatants were collected at 24 h after LPS + IFN-γ
stimulation and centrifuged at 1200 rpm for 3min to remove cell
debris. The supernatant protein concentrations were measured
using a spectrophotometer (NanoDrop R© ND-1000, Thermo
Fisher Scientific Inc., Wilmington, DE, USA) at the A280
absorbance level. Levels of IL-12 and IL-10 in supernatants were
assayed using high-sensitivity ELISA kits (Quantikine R© ELISA,
R&D Systems) according to the manufacturer specifications and
the well absorbances were read at 450 nm using an ELISA plate
reader.
Real-Time Polymerase Chain Reaction
For the in vivo study, total RNA was prepared from spleen
and hippocampal tissues using an RNeasy R© Mini Kit
(QIAGEN, Austin, Texas, USA) according to the manufacturer
specifications. Briefly, recommended amounts of tissue (25mg)
were placed into the kit lysis buffer (containing an additional 10
µl β-mercaptoethanol for every 1ml lysis buffer) and processed
as recommended. For the in vitro study, BV2 and RAW 264.7
cells were collected at 24 h after LPS + IFN-γ stimulation and
RNA was isolated using the same method as that described
above. As per the manufacturer instructions, RNA was eluted
with 30–50 µl of RNase-free H2O. Samples were immediately
aliquoted and stored at −80◦C until use. RNA concentrations
were quantified using a spectrophotometer (NanoDrop R© ND-
1000) at the A260 absorbance level. The purity of the RNA was
assessed by calculating the A260/A280 ratio of each sample.
cDNA was synthesized from 1 µg of total RNA for each sample
using the Maxime RT PreMix kit (Oligo dT Primer, iNtRON
Biotechnology, Inc., Seongnam-si, Gyeonggi-do, Korea). Diluted
cDNA was amplified with SYBR R© Green PCR Master Mix
(Applied Biosystems, Foster City, CA, USA) in a final reaction
volume of 50 µl. The PCR reaction was performed using an ABI
prism 7500 sequence detector (Applied Biosystems). The PCR
program included initial denaturation at 95◦C for 10 s followed
by 40 cycles of 95◦C for 5 s, 60◦C for 34 s, 95◦C for 15 s, 60◦C
for 1min, and 95◦C for 15 s. The nucleotide sequences of the
primers used in this study are shown in Table 1. The cycling
threshold values for TNF-α, CXCL-10, IL-1β, arginase-1, IL-10,
and Ym-1 were normalized to those of β-actin.
Flow Cytometry
For fluorescent-activated cell sorting (FACS) analyses, fresh
spleen and hippocampal tissues were placed on a petri dish on ice
and dissociated into small pieces using a clean razor blade. FACS
buffer (PBS containing 0.2% bovine serum albumin and 5mM
glucose) supplemented with 0.5 mg/mL type I collagenase was
added to the dissociated tissues and the samples were incubated
for 10min. The samples were then centrifuged at 250 × g for
3min and the resultant pellets were each resuspended in 500
µl FACS buffer. Following additional centrifugation at 250 ×
g for 3min, the pellets were re-collected and the samples were
blocked in anti-mouse CD16/CD32 (1:50, BD Biosciences, San
Jose, CA, USA) for 10min on ice. After blocking, the samples
were centrifuged at 250 × g for 3min and the resulting pellets
were incubated with one of two antibody sets (M1 set: CD11b-
PE, F4/80-APC, and CD40-FITC; M2 set: CD11b-FITC, F4/80-
APC, CD206-PE) diluted in FACS buffer. Thereafter, the cell
suspensions were filtered through a 40-µm nylon mesh cell
strainer. Fluorescent cells were immediately identified using a
flow cytometer (LSR II, BD bioscience, San Jose, CA, USA) and
analyzed using FlowJo software version 10 (FlowJo LLC, Ashland,
OR, USA). Primary gating was based on forward scatter (FSC)
and side scatter (SSC) to isolate single cell events. Cell debris,
dead cells, or doublets were eliminated by excluding low FSC and
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TABLE 1 | DNA sequences of the primers for reverse transcriptase polymerase
chain reaction.
Mouse cDNA Primer sequences
TNF-α Forward, 5′ - ACGGCATGGATCTCAAAGAC - 3′
Reverse, 5′ - AGATAGCAAATCGGCTGACG - 3′
CXCL10 Forward, 5′ - GGATGGCTGTCCTAGCTCTG - 3′
Reverse, 5′ - TGAGCTAGGGAGGACAAGGA - 3′
IL-1β Forward, 5′ - TGTCTTGGCCGAGGACTAAGG - 3′
Reverse, 5′ - TGGGCTGGACTGTTTCTAATGC−3′
Arginase-1 Forward, 5′ - GAACACGGCAGTGGCTTTAAC - 3′
Reverse, 5′ - TGCTTAGCTCTGTCTGCTTTGC - 3′
IL-10 Forward, 5′ - GCTCTTACTGACTGGCATGAG - 3′
Reverse, 5′ - CGCAGCTCTAGGAGCATGTG - 3′
Ym-1 Forward, 5′ - GGGCATACCTTTATCCTGAG - 3′
Reverse, 5′ - CCACTGAAGTCATCCATGTC - 3′
β-actin Forward, 5′ - AGAGGGAAATCGTGCGTGAC - 3′
Reverse, 5′ - CAATAGTGATGACCTGGCCGT−3′
high SSC. Macrophage/microglia were identified using CD11b
and F4/80. The M1 and M2 polarization states were identified by
CD40 and CD206 expression, respectively.
Statistical Analysis
Data are expressed as the mean ± standard error of the
mean (SEM). The groups were compared using a one-way
analysis of variance followed by Tukey post hoc tests and
unpaired t-tests as appropriate. Linear regression was used to
estimate the slopes of the fiber volley (FV)/fEPSP ratios in the
electrophysiological experiments. Differences with a P < 0.05
were deemed statistically significant. All statistical analyses were
performed using Prism version 5.0 software (GraphPad Software
Inc., La Jolla, CA, USA).
RESULTS
EPO Minimizes Cognitive Dysfunction and
Synaptic Dysfunction Following Surgery
With regard to the open field testing, there were no significant
between-group differences in the distances the mice moved at
48 h post-surgery (Figure 1A, P = 0.774). For evaluations of
learning and memory, there were significant between-group
differences in the latency times in the passive avoidance test
(Figure 1B, P = 0.006), and the duration spent exploring the
novel object in the novel object recognition test (Figure 1C,
P < 0.001). The latency times in the passive avoidance test
were significantly shorter in the Surgery group compared to
the control and EPO-surgery groups. Furthermore, mice in the
surgery group spent significantly less time exploring the novel
object in the novel object recognition task in comparison to all
other groups. These data suggest that rhEPO prevented and/or
ameliorated POCD in mice.
To investigate the effects of surgery and rhEPO on
synaptic function, we measured synaptic strength and LTP in
hippocampal slices using fEPSPs at 48 h post-surgery. Synaptic
strength was assessed by generating I/O curves and comparing
the slopes of the FV/fEPSP ratios in SC-CA1 hippocampal
synapses. The synaptic strength was significantly different
between the groups (Figure 1D, P = 0.010). The Surgery
group had significantly lower fEPSP slopes at similar pre-
synaptic FV amplitudes when compared with the control group,
indicating a decrease in synaptic strength. The surgery-induced
decrease was significantly ameliorated in the EPO-surgery group.
Next, we investigated LTP in SC-CA1 synapses, which plays
a key role in memory and cognitive function (Bliss and
Collingridge, 1993). The differences in LTP between the groups
were also statistically significant (Figure 1E, P < 0.001). LTP
was significantly attenuated in the surgery group compared to
control group. Moreover, LTP was almost completely restored in
the EPO-surgery group, to a level comparable with that of the
control group.
Finally, we measured the protein expression levels of IL-1β
and TNF-α in hippocampal tissues (Figure 1F), since these pro-
inflammatory cytokines have been reported to underlie POCD
(Terrando et al., 2010; Zhang et al., 2016) and high levels of IL-1β
can interfere with synaptic plasticity and LTP (Rachal Pugh et al.,
2001). There were a significant between-group differences in
levels of IL-1β and TNF-α in the hippocampus (IL-1β, P< 0.001;
TNF-α, P < 0.001). The levels of IL-1β and TNF-α in the
hippocampus were significantly higher in the surgery group
compared to the control and EPO-control groups. Importantly,
rhEPO administration partially attenuated the surgery-induced
up-regulation of pro-inflammatory cytokines in the EPO-surgery
group.
EPO Alters the Expression of Selected M1-
and M2-Related Genes in Spleen and
Hippocampal Tissues Following Surgery
To evaluate M1 versus M2 macrophage phenotype of the mice in
each group, we characterized the expression profiles of selected
genes related to the M1 and M2 phenotypes in the spleen
(Figure 2) and hippocampus (Figure 3) at 6 and 48 h post-
surgery. There were significant differences between the groups in
the expression levels of most of the selected genes (Figure 2A,
spleen 6 h post-surgery: TNF-α, P = 0.013; CXCL10, P = 0.010;
Arginase-1, P = 0.001; IL-10, P = 0.002; Figure 2B, spleen 48 h
post-surgery: TNF-α, P < 0.001; CXCL10, P < 0.001; Arginase-
1, P < 0.001; IL-10, P < 0.001; Figure 3A, hippocampus 6 h
post-surgery: TNF-α, P = 0.002; CXCL10, P = 0.108; Arginase-
1, P = 0.017; IL-10, P < 0.001; Figure 3B, hippocampus 48 h
post-surgery: TNF-α, P = 0.002; CXCL10, P < 0.001; Arginase-
1, P < 0.001; IL-10, P < 0.001). The mRNA expression of
M1-related genes including TNF-α and CXCL10 was increased
in the surgery group, and this increase was attenuated in the
EPO-surgery group. Conversely, significant increases in M2-
related gene expression including arginase-1 and IL-10 were only
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FIGURE 1 | Assessments of Neurobehavioral function and hippocampal synaptic function 48 h following abdominal surgery. (A) Total distance moved in the open field
(cm) (n = 11 per group). (B) Latency to enter the dark compartment in the test phase of the passive avoidance test (s) (n = 11 per group). (C) Proportion of time spent
exploring the novel object in the test phase of the novel object recognition test (%) (n = 8 per group). (D) Upper graph, scatter plot of input/output (I/O) relationships
for synaptic strength in hippocampal Schaffer collateral-CA1 synapses in each group. I/O relationships were calculated as the ratio of the fEPSP slope (between 20
and 80% of the rising part of the fEPSP) to the fiber volley amplitude. Lower graph, averaged slopes of I/O relationships for each group. (E) Upper graph, time course
for long-term potentiation (LTP) in each group. LTP was calculated as the ratio of averaged fEPSP slopes after high frequency stimulation for 1 h to the baseline fEPSP
slope before high frequency stimulation (20min). Lower graph, averaged LTP values corresponding to the time course of LTP in the upper trace. (n = 6 slices from 3
mice per group). (F) Protein expression levels of IL-1β and TNF-α in the hippocampus (n = 5 per group). Control: naïve control; Surgery: abdominal surgery only;
EPO-Control: erythropoietin administration only; and EPO-Surgery: erythropoietin administration and abdominal surgery. *P < 0.05, **P < 0.01, and ***P < 0.001.
observed in the EPO-surgery group. Differences in M1 and M2-
related gene expression among the groups were more prominent
at 48 h post-surgery (Figures 2B, 3B) compared to 6 h post-
surgery (Figures 2A, 3A). In addition, no significant differences
in gene expression were observed between the control and EPO-
control groups. Both the spleen and hippocampus demonstrated
similar patterns of gene expression in each group.
EPO Increases Macrophage/Microglia M2
Phenotype in the Presence of
M1-Polarizing Stimuli in Vitro
To confirmwhether rhEPO directly alters the phenotype patterns
of macrophage/microglia, we assessed the effects of rhEPO on the
mouse macrophage cell line RAW264.7 and the mouse microglia
cell line BV2. After the stimulation with M1 inducer (LPS and
IFN-γ), rhEPO, or both, there were significant differences in the
mRNA expression of M1- and M2-related genes (M1: TNF-α,
CXCL10, and IL-1β; M2: arginase-1, IL-10, and Ym-1) between
the groups in the RAW264.7 (Figure 4A: TNF-α, P < 0.001;
CXCL10, P < 0.001; IL-1β, P < 0.001; Figure 5A: arginase-
1, P < 0.001; IL-10, P = 0.003; Ym-1, P < 0.001) and BV2
(Figure 4C: TNF-α, P < 0.001; CXCL10, P < 0.001; IL-1β,
P < 0.001; Figure 5C: arginase-1, P < 0.001; IL-10, P < 0.001;
Ym-1, P < 0.001). In both cell lines, LPS+INF-γ increased the
mRNA expression of M1-related genes, and this was suppressed
by treatment with rhEPO (Figures 4A,C). M2-related genes were
only induced following LPS+INF-γ and treatment with rhEPO
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FIGURE 2 | mRNA expression of selected M1-related and M2-related genes in the spleen following abdominal surgery in mice. (A) Expression levels 6 h post-surgery.
(B) Expression levels 48 h post-surgery (n = 6 at each time point in each group). β-actin was used for normalization. *P < 0.05, **P < 0.01, and ***P < 0.001.
in RAW264.7 cells (Figure 5A). The patterns of gene expression
for IL-10 and Ym-1 were similar in both the RAW264.7 and BV2
cell lines; however, arginase-1 gene expression was significantly
suppressed by LPS+INF-γ in BV2 cells (Figure 5C). In addition,
we measured secreted protein levels of IL-12 and IL-10 in the
cell lines following LPS+INF-γ in the presence or absence of
rhEPO treatment. After LPS+INF-γ with rhEPO treatment, IL-
12 levels were significantly decreased [Figure 4B (RAW264.7),
P = 0.008; Figure 4D (BV2), P < 0.001] and IL-10 was
significantly increased in both cell lines [Figure 5B (RAW264.7),
P= 0.016; Figure 5D (BV2), P= 0.005] compared to LPS+INF-γ
alone.
EPO Alters the Pattern of
Macrophage/Microglia Phenotype
Following Surgery
Flow cytometry was used to quantitatively assess M1 versus
M2 phenotype of macrophages/microglia in the post-surgery
mice. The cells were labeled with antibodies specific for
macrophages/microglia (CD11b and F4/80); of these, CD40+
macrophages/microglia were classed as M1-phenotype and
CD206+ macrophages/microglia were classed as M2-phenotype
in the spleen (Figure 6) and the hippocampus (Figure 7). The
EPO-control group was omitted from this analysis because
EPO did not affect the phenotype of the resting state-
macrophage/microglia as shown previously (Figures 2–5). The
relative proportions of CD40+ cells and CD206+ cells among the
CD11b+/F4/80+ cells were compared, and significant differences
were found between the groups (Figure 6C: CD40+ cells
in the spleen, P < 0.001; Figure 6D: CD206+ cells in the
spleen, P < 0.001; Figure 7C: CD40+ cells in the hippocampus,
P = 0.005; Figure 7D: CD206+ cells in the hippocampus,
P < 0.001). As depicted in Figure 6C, the proportion of CD40+
cells in the spleen was significantly increased in the surgery
group compared to the control group, whereas an increased
proportion of CD40+ cells was not observed in the EPO-
surgery group. Conversely, there were no significant differences
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FIGURE 3 | mRNA expression of selected M1-related and M2-related genes in the hippocampus following abdominal surgery in mice. (A) Expression levels 6 h
post-surgery. (B) Expression levels 48 h post-surgery (n = 6 at each time point in each group). β-actin was used for normalization. *P < 0.05, **P < 0.01, and
***P < 0.001.
in the proportion of CD206+ cells between the surgery and
control groups; however, the proportion of CD206+ cells was
significantly greater in the EPO-surgery group compared to the
control and surgery groups (Figure 6D). Similar patterns of
polarization were observed in the hippocampus compared to the
spleen (Figures 7C,D).
Arginase Inhibition Abolishes EPO-Induced
Improvements in POCD
Arginase is thought to mediate the anti-inflammatory effects of
M2 macrophages (Pesce et al., 2009). Therefore, we assessed
post-operative cognitive function and inflammatory cytokine
levels in the hippocampus following administration of a specific
arginase inhibitor with EPO in order to estimate the influence of
macrophage M2 polarization on POCD. There were significant
between-group differences in the results from passive avoidance
and novel object recognition tests (Figure 8A: passive avoidance
test, P = 0.001; Figure 8B: novel object recognition test,
P < 0.001). As we previously observed in the passive avoidance
test, the latency to enter the dark box of the surgery group
was significantly shorter than that of the control group, whereas
the latency in the EPO-surgery group was similar to that of
the control group. Arginase inhibition prevented the restorative
effect of EPO on the latency, such that the latency of the EPO-
surgery-AI group was similar to that of the surgery group. In
the novel object recognition test, the time spent exploring the
novel object was close to 50% in the EPO-surgery-AI group,
suggesting that these mice had trouble in distinguishing the novel
object, and thus impaired cognitive function. Furthermore, the
levels of the pro-inflammatory cytokines IL-1β and TNF-α in
the hippocampus were significantly different between the groups
(Figure 8C: IL-1β, P < 0.001; Figure 8D: TNF-α, P < 0.001).
The levels were higher in the EPO-surgery-AI group than in the
control and EPO-surgery groups.
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FIGURE 4 | In vitro evaluation of the M1 phenotype in RAW 264.7 and BV2 cells after lipopolysaccharide (LPS) and interferon (IFN)-γ treatment. The mRNA
expression of selected M1-related genes in RAW264.7 (A) and BV2 (C) cells. IL-12 protein expression in RAW 264.7 (B) and BV2 (D) cell supernatants. Control:
non-stimulated cells; LPS+IFN-γ: M1 stimulation; EPO-Control: erythropoietin treatment only; EPO-LPS+IFN-γ: erythropoietin treatment with M1 stimulation. β-actin
was used for normalization. *P < 0.05, **P < 0.01, and ***P < 0.001.
DISCUSSION
The main findings of this study are as follows: (1) EPO
treatment suppressed increases in pro-inflammatory cytokines
in the hippocampus following surgery, and appeared to prevent
or alleviate the post-operative impairments in LTP and synaptic
dysfunction, which was associated with decreased POCD. (2)
EPO increased the proportion of macrophages/microglia with
an M2-phenotype in vivo in spleen and hippocampal tissues
post-surgery and in vitro after stimulation of M1 inducers. (3)
Arginase inhibition abolished EPO-associated improvements in
cognitive function and neuroinflammation post-surgery.
The core pathophysiology of POCD has been reported
to involve neuroinflammation that results from systemic
inflammation after surgical damage (Degos et al., 2013; Vacas
et al., 2014). Elevated levels of pro-inflammatory cytokines such
as IL-1β in the hippocampus can impair synaptic function
and lead to cognitive dysfunction (Rachal Pugh et al., 2001;
Cibelli et al., 2010; Terrando et al., 2010; Zhang et al., 2016).
In our study, EPO improved the behavioral indicators of
POCD, and prevented the increase in pro-inflammatory cytokine
expression in the hippocampus post-surgery. Although previous
evidence indicates that EPO has anti-inflammatory effects in
the central nervous system and on the periphery (Agnello
et al., 2002; Nairz et al., 2011), the present study is the first
to demonstrate that the anti-inflammatory effects of EPO may
be attributable to M2-phenotype macrophage. Specifically, we
found that EPO increased the expression ofM2-related genes and
increased the proportion of M2-like macrophages in the spleen
and hippocampus post-surgery, and our in vitro experiment
demonstrated that EPO could directly change the phenotype
of activated macrophage. Furthermore, the effects of EPO on
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FIGURE 5 | In vitro evaluation of the M2 phenotype in RAW 264.7 and BV2 cells after LPS+IFN-γ treatment. The mRNA expression levels of selected M2-related
genes in RAW 264.7 (A) and BV2 (C) cells. IL-10 protein expression in RAW 264.7 (B) and BV2 (D) cell supernatants. β-actin was used for normalization. *P < 0.05,
**P < 0.01, and ***P < 0.001.
cognitive function and neuroinflammation were abolished by the
inhibition of arginase, which is thought to mediate M2 anti-
inflammatory effects. Macrophages can be characterized as M1
or M2 according to the metabolism of arginine (Rath et al.,
2014; Yang and Ming, 2014). While M1 macrophages metabolize
arginine via inducible nitric oxide synthase to produce the
cytotoxic radical nitric oxide, M2macrophages utilize arginase to
metabolize arginine to ornithines and polyamines that promote
cell proliferation and tissue repair. Therefore, it may be inferred
that the effect of EPO on macrophage phenotype led to the
suppression of pro-inflammatory cytokine expression in the
hippocampus and thus prevented POCD. Additionally, our in
vitro results indicate that EPO did not induce an M2 phenotype,
but rather inducedM2 switching in the presence of M1 activation
cues. We did not observe any changes in M1 or M2-related gene
expression when cells were treated with EPO in the absence of
M1 inducers. Consistent with this idea, EPO did not alter the
expression of any M1- or M2-related genes in the absence of a
surgical insult in vivo.
EPO receptors on erythroid cells are comprised of two
identical EPO receptor subunits, whereas non-erythroid cells
such as immune cells express a heterodimeric receptor that
consists of an EPO receptor subunit and a β common receptor
subunit (Brines and Cerami, 2012). Thus, EPO receptors in
erythroid tissues have a much higher affinity for EPO than those
in other tissues. Indeed, the activation of non-hematopoietic EPO
receptors may require a higher dose of EPO than that used to
stimulate hematopoietic EPO receptors. For example, 600 U/kg
EPO is sufficient to reduce the need for perioperative allogenic
blood transfusion in patients (Steuber et al., 2016; Zhao et al.,
2016). In contrast, Nairz et al. demonstrated that 5,000 U/kg
EPO in mice influenced the actions of activated macrophages
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FIGURE 6 | Proportions of M1 and M2 macrophages in the spleen 48 h following abdominal surgery. (A) Representative flow cytometry plots of F4/80+/CD11b+
cells (left row) and CD40+ cells (right row) in the cellular populations of each group. (B) Representative flow cytometry plots of F4/80+/CD11b+ cells (left row) and
CD206+ cells (right row). (C) Quantification of the ratio of M1 macrophages (CD40+) to total macrophages (F4/80+/CD11b+). (D) Quantification of the ratio of M2
macrophages (CD206+) to total macrophages (n = 5 per group). **P < 0.01 and ***P < 0.001.
through the EPO receptor (Nairz et al., 2011). For this reason,
we used a dose of 5,000 U/kg EPO in our experiment to test the
utility of EPO for altering macrophage polarization in POCD.
One limitation of this approach is that high doses of EPO are
associated with an increased risk of thrombosis in clinical settings
(Bohlius et al., 2006; Corwin et al., 2007; van der Meer and van
Veldhuisen, 2011). Alternative compounds such as carbamylated
EPO are currently being developed to circumvent such side
effects. Carbamylated EPO is an EPO receptor agonist that lacks
erythropoietic and hematopoietic activities (Brines and Cerami,
2012), which may make it safer for controlling the postoperative
innate immune response in patients. Carbamylated EPO was
recently tested in several disease models and showed promising
results (van Rijt et al., 2014; Chen et al., 2015).
Although little is known about how macrophage polarization
affects postoperative recovery, considerable insight can be
derived from studies of infection and cancer (Labonte et al.,
2014). M1 macrophage polarization is largely related to
protection against bacterial infection and cancer based on
the bactericidal and anti-tumoral effects of M1 macrophages.
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FIGURE 7 | Proportions of M1 and M2 macrophage/microglia in the mouse hippocampus 48 h following abdominal surgery. (A) Representative flow cytometry plots
of F4/80+/CD11b+ cells (left row) and CD40+ cells (right row) in the cellular populations of each group. (B) Representative flow cytometry plots of F4/80+/CD11b+
cells (left row) and CD206+ cells (right row). (C) Quantification of the ratio of M1 macrophages/microglia (CD40+) to total macrophages/microglia (F4/80+/CD11b+).
(D) Quantification of the ratio of M2 macrophages/microglia (CD206+) to total macrophages/microglia (n = 6 per group). *P < 0.05 and **P < 0.01.
Alternatively, viral infection more commonly leads to M1
polarization and the severity of inflammation is often correlated
with disease severity. Therefore, M2 polarization may play a role
in alleviating the severity of viral infection. Expanding on this
idea, our study suggests that M2 polarization alleviates surgery-
induced aseptic inflammation to prevent POCD.
This study had some limitations. First, although the trajectory
of cognitive function should be evaluated over a period that
includes complete surgical recovery in order to properly assess
POCD (Nadelson et al., 2014), we assessed cognitive function
in mice at a single time point 2 days after abdominal surgery.
This time point was selected based on the results of a previous
study using a similar surgery model that reported that cognitive
impairments were most pronounced during the first week post-
surgery (Hovens et al., 2014). Second, we were not able to
distinguish between the effects of EPO on microglia versus
macrophages in our in vivo experiment; blood-brain barrier
permeability can be increased with surgery (Bi et al., 2017;
Yang et al., 2017), and systemically administered EPO has
been reported (observed?) to cross the blood-brain barrier not
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FIGURE 8 | Neurobehavioral functional assessments and hippocampal pro-inflammatory cytokine expression after arginase inhibitor administration. The
EPO-Surgery-AI group received a selective arginase inhibitor prior to each erythropoietin treatment, and received abdominal surgery. (A) Latency to enter the dark
compartment in the test phase of the passive avoidance test (s). (B) Proportion of time spent exploring the novel object in the test phase of the novel object recognition
test (%) [n = 8 per group in (A,B)]. (C) IL-1β and (D) TNF-α protein expression in the hippocampus [n = 5 per group in (C,D)]. *P < 0.05, **P < 0.01, and ***P < 0.001.
only in some brain injury models (Brines et al., 2000; Sirén
et al., 2001) but also in healthy mice (Ehrenreich et al., 2004).
However, a previous study indicated that the infiltration of
systemic macrophages into the hippocampus is essential for
the development of POCD (Degos et al., 2013), suggesting that
macrophages might be largely responsible for the effects of EPO
in POCD. Moreover, the direct stimulation of microglia with
EPO in vitro produced a different pattern in arginase expression
from that observed in the hippocampus. Third, we could not
exclude the possibility that EPO affects macrophage/microglia
partly through the actions on the other cell types in vivo since
various cell types have EPO receptors. Fourth, we did not include
a group that only received anesthesia in this study, which may
be a weakness of the study since anesthesia has been reported
to contribute to POCD (Arora et al., 2014). Finally, narcotic
analgesics are known risk factors of postoperative cognitive
dysfunction (Bilotta et al., 2013), and therefore the effect of
tramadol given to the mice undergoing surgery cannot be
completely excluded.
CONCLUSION
Our data support the idea that EPO shifts macrophage activation
from anM1 to anM2 phenotype, and this may be associated with
its ability to prevent POCD.
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